PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 9, 2012, Pages

  Ng, Jason M ^a   Azuma, Koichiro ^a   Kelley, Carol ^a   Pencek, Richard ^a   Radikova, Zofia ^a   Laymon, Charles ^a   Price, Julie ^a   Goodpaster, Bret H ^a   Kelley, David E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Insulin sensitivity; Positron emission tomography imaging

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; FLUORODEOXYGLUCOSE F 18; INSULIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUTEAL FEMORAL ADIPOSE TISSUE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID STORAGE; MUSCLE MASS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKELETAL MUSCLE; STEADY STATE; SUBCUTANEOUS FAT; TISSUE METABOLISM; VOLUMETRY;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADIPOSITY; ADULT; BODY MASS INDEX; COHORT STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; MALE; OVERWEIGHT; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 84868333588     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00282.2012     Document Type: Article

References (46)

1. Amati F, Pennant M, Azuma K, Dubé JJ, Toledo FG, Rossi AP, Kelley DE, Goodpaster BH. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity (Silver Spring) 20: 1115-1117, 2012.
2. Bertoldo A, Peltoniemi P, Oikonen V, Knuuti J, Nuutila P, Cobelli C. Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a fourcompartment five-rate-constant model. Am J Physiol Endocrinol Metab 281: E524-E536, 2001.
3. Bier DM, Brosnan JT, Flatt JP, Hanson RW, Heird W, Hellerstein MK, Jéquier E, Kalhan S, Koletzko B, Macdonald I, Owen O, Uauy R. Report of the IDECG Working Group on lower and upper limits of carbohydrate and fat intake. International Dietary Energy Consultative Group. Eur J Clin Nutr 53, Suppl 1: S177-S178, 1999.
4. Bingley CA, Gitau R, Lovegrove JA. Impact of menstrual cycle phase on insulin sensitivity measures and fasting lipids. Horm Metab Res 40: 901-906, 2008.
5. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 4: 499-502, 2001.
6. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46: 459-469, 2003.
7. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab 237: E214-E223, 1979.
8. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444: 881-887, 2006.
9. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10: 497-511, 1990.
10. Golan R, Shelef I, Rudich A, Gepner Y, Shemesh E, Chassidim Y, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Ben Avraham S, Witkow S, Liberty IF, Tangi-Rosental O, Sarusi B, Stampfer MJ, Shai I. Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. Diabetes Care 35: 640-647, 2012.
11. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 71: 885-892, 2000.
12. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46: 1579-1585, 1997.
13. Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563, 2006.
14. Hamacher K, Coenen HH, Stöcklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27: 235-238, 1986.
15. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
16. Huang SC, Williams BA, Barrio JR, Krivokapich J, Nissenson C, Hoffman EJ, Phelps ME. Measurement of glucose and 2-deoxy-2-[18F]fluoro-D-glucose transport and phosphorylation rates in myocardium using dual-tracer kinetic experiments. FEBS Lett 216: 128-132, 1987.
17. Jensen MD. Gender differences in regional fatty acid metabolism before and after meal ingestion. J Clin Invest 96: 2297-2303, 1995.
18. Jensen MD, Kanaley JA, Reed JE, Sheedy PF. Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr 61: 274-278, 1995.
19. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792, 2006.
20. Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60: 2441-2449, 2011.
21. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 278: E941-E948, 2000.
22. Kelley DE, Williams KV, Price JC, Goodpaster B. Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle. J Nucl Med 40: 1798-1804, 1999.
23. Koutsari C, Snozek CL, Jensen MD. Plasma NEFA storage in adipose tissue in the postprandial state: sex-related and regional differences. Diabetologia 51: 2041-2048, 2008.
24. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 72: 1150-1162, 1983.
25. Lemieux S, Despres JP, Moorjani S, Nadeau A, Theriault G, Prud'homme D, Tremblay A, Bouchard C, Lupien PJ. Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia 37: 757-764, 1994.
26. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 27: 661-670, 2000.
27. Louet JF, LeMay C, Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6: 180-185, 2004.
28. Matute ML, Kalkhoff RK. Sex steroid influence on hepatic gluconeogenesis and glucogen formation. Endocrinology 92: 762-768, 1973.
29. Minoshima S, Berger KL, Lee KS, Mintun MA. An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med: 1579-1585, 1992.
30. Nielsen S, Guo Z, Albu JB, Klein S, O'Brien PC, Jensen MD. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 111: 981-988, 2003.
31. Proctor DN, O'Brien PC, Atkinson EJ, Nair KS. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol Endocrinol Metab 277: E489-E495, 1999.
32. Rebrin K, Steil GM, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98: 741-749, 1996.
33. Rincon J, Holmäng A, Wahlström EO, Lönnroth P, Björntorp P, Zierath JR, Wallberg-Henriksson H. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45: 615-621, 1996.
34. Romanski SA, Nelson RM, Jensen MD. Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am J Physiol Endocrinol Metab 279: E455-E462, 2000.
35. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, Jensen MD, Parati G, Lopez-Jimenez F. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 31: 737-746, 2010.
36. Seidell JC, Han TS, Feskens EJ, Lean ME. Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulindependent diabetes mellitus. J Intern Med 242: 401-406, 1997.
37. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC; Hoorn study. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care 27: 372-377, 2004.
38. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord 28: 402-409, 2004.
39. Stumvoll M, Jacob S, Wahl HG, Hauer B, Löblein K, Grauer P, Becker R, Nielsen M, Renn W, Häring H. Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab 85: 3740-3745, 2000.
40. Vague J. Sexual differentiation, a factor affecting the forms of obesity. Presse Med 55: 339-340, 1947.
41. Virtanen KA, Iozzo P, Hällsten K, Huupponen R, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Lönnroth P, Knuuti J, Ferrannini E, Nuutila P. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study. Diabetes 54: 2720-2726, 2005.
42. Virtanen KA, Lönnroth P, Parkkola R, Peltoniemi P, Asola M, Viljanen T, Tolvanen T, Knuuti J, Rönnemaa T, Huupponen R, Nuutila P. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 87: 3902-3910, 2002.
43. Virtanen KA, Peltoniemi P, Marjamäki P, Asola M, Strindberg L, Parkkola R, Huupponen R, Knuuti J, Lönnroth P, Nuutila P. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxyglucose {[(18)F]FDG} and PET in combination with microdialysis. Diabetologia 44: 2171-2179, 2001.
44. Votruba SB, Jensen MD. Short-term regional meal fat storage in nonobese humans is not a predictor of long-term regional fat gain. Am J Physiol Endocrinol Metab 302: E1078-E1083, 2012.
45. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17: 536-546, 1993.
46. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362, 2005.